Audentes Therapeutics Stock Forecast

Buy or Hold candidate since Jun 24, 2026 Loss -6.15%

The Audentes Therapeutics Inc. stock price gained 1.24% on the last trading day (Monday, 13th Jul 2026), rising from $2.41 to $2.44. During the last trading day the stock fluctuated 5.53% from a day low at $2.35 to a day high of $2.48. The price has been going up and down for this period, and there has been a -4.69% loss for the last 2 weeks. Volume fell on the last day by -99 thousand shares and in total, 304 thousand shares were bought and sold for approximately $740.82 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 50.25% during the next 3 months and, with a 90% probability hold a price between $2.42 and $4.18 at the end of this 3-month period.

BOLD Signals & Forecast

The Audentes Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.47. On a fall, the stock will find some support from the long-term average at approximately $1.86. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 24, 2026, and so far it has fallen -6.15%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Audentes Therapeutics Inc. stock

Audentes Therapeutics Inc. finds support from accumulated volume at $2.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.130 between high and low, or 5.53%. For the last week the stock has had daily average volatility of 3.92%.

Our recommended stop-loss: $2.34 (-3.90%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 79 and this increases the risk substantially. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (BOLD) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Audentes Therapeutics Inc. to open at $2.42, and during the day (based on 14 day Average True Range), to move between $2.37 and $2.51, which gives a possible trading interval of +/-$0.139 (+/-5.87%) up or down from last closing price. If Audentes Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.41 (1.23%) than the resistance at $2.50 (2.46%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Audentes Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Audentes Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.635 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $2.42 ( 0.683%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk